Delivery Order SPE2DR25D3505-SPE2DR26F94E5
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $9,280.05 to supply Bicillin L-A 1,200,000 Units 2ML, a penicillin-based antibiotic used for treating bacterial infections across military and federal healthcare systems. The contract is a firm fixed price delivery order with an ultimate completion date of December 5, 2025, and was awarded on a competitive, non-set-aside basis. Performance will occur at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $2,795.08 to AmerisourceBergen Drug Corp for the supply of Bicillin L-A 1,200,000 Units 2ML, a penicillin-based antibiotic product. The contract, issued on December 5, 2025, with an ultimate completion date of December 8, 2025, utilizes firm fixed-price pricing and was competitively awarded without set-aside designation. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Bicillin L-A 1,200,000 Units 2ML, an antibiotic pharmaceutical product. This firm fixed-price delivery order, valued at $3,230.05, represents a non-competitive set-aside contract and is scheduled for completion by December 9, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters...
- The Defense Logistics Agency awarded a $1,535.02 firm fixed price delivery order to AmerisourceBergen Drug Corp for Bicillin L-A 1,200,000 units in 2mL vials, with an ultimate completion date of May 5, 2025. This non-set-aside contract, awarded May 2, 2025, represents a direct purchase of pharmaceutical inventory to support federal healthcare operations. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on December 9, 2025, for the supply of Bicillin L-A 2,400,000 units in 4ml formulations. This firm fixed price delivery order, valued at $7,145.20, is scheduled for completion by December 10, 2025, with performance occurring at the vendor's Conshohocken facility. The award represents a non-competitive delivery order executed...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Bicillin L-A 1,200,000 units in 2mL formulations, with a ceiling value of $1,443.54. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement from the Defense Logistics...
- The Defense Logistics Agency has awarded a delivery order valued at $1,443.54 to AmerisourceBergen Drug Corp for the supply of Bicillin L-A 1,200,000 units in 2 mL formulations, with a completion date of June 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Bicillin L-A 1,200,000 units (2mL formulation) valued at $6,904.59. This is a firm fixed price delivery order with no set-aside designation, competitively awarded on June 2, 2025, with an ultimate completion date of June 3, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a $5,590.16 delivery order to AmerisourceBergen Drug Corp for the supply of Bicillin L-A 1,200,000 Units 2ML, with an ultimate completion date of November 25, 2025. This competitively awarded, firm fixed price contract contains no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be performed and delivered from AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,443.54 to AmerisourceBergen Drug Corp for Bicillin L-A 1,200,000 units in 2ml vials. The contract is non-competitive with no set-aside designation and was awarded on July 14, 2025, with an ultimate completion date of July 15, 2025. This delivery order is issued under a firm fixed price arrangement with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents...
- SPE2DR25D3505Indefinite Delivery Contract
- SPE2DR25D3505-SPE2DR26F94E5Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,397.53 for Bicillin L-A 1,200,000 Units 2ML, a penicillin-based antibiotic commonly used for treating bacterial infections. This competitively awarded, firm fixed-price delivery order was issued on December 1, 2025, with an ultimate completion date of December 2, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a prime vendor for the Defense Logistics Agency's medical supply chain, AmerisourceBergen supplies a broad portfolio of pharmaceutical products and medical supplies to support military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. The company's extensive federal contracting history demonstrates its capability to fulfill varied medical procurement requirements across multiple therapeutic domains through open competition and firm fixed-price arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 11/30/25 |